UNITEDHEALTH GROUP INC (UNH) Stock Earnings Estimates
USA • New York Stock Exchange • NYSE:UNH • US91324P1021
276.65 USD
+8.1 (+3.02%)
At close: Feb 6, 2026
276.1 USD
-0.55 (-0.2%)
After Hours: 2/6/2026, 8:09:50 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 371.622B 14.64% | 400.278B 7.71% | 447.567B 11.81% | 445.989B -0.35% | 461.233B 3.42% | 488.584B 5.93% | 545.26B 11.60% | 587.648B 7.77% | 620.227B 5.54% | 654.474B 5.52% | 690.464B 5.50% | |
| EBITDA YoY % growth | 36.33B 14.12% | 36.386B 0.15% | 23.325B -35.90% | 29.07B 24.63% | 32.599B 12.14% | 37.998B 16.56% | 44.587B 17.34% | 54.301B 21.79% | 59.296B 9.20% | 62.85B 5.99% | 66.704B 6.13% | |
| EBIT YoY % growth | 32.358B 13.80% | 32.287B -0.22% | 18.964B -41.26% | 23.977B 26.43% | 27.42B 14.36% | 32.845B 19.78% | 38.374B 16.83% | 46.352B 20.79% | 50.907B 9.83% | 53.998B 6.07% | 57.365B 6.24% | |
| Operating Margin | 8.71% | 8.07% | 4.24% | 5.38% | 5.94% | 6.72% | 7.04% | 7.89% | 8.21% | 8.25% | 8.31% | |
| EPS YoY % growth | 25.12 13.20% | 27.92 11.15% | 16.31 -41.58% | 18.01 10.42% | 19.95 10.76% | 23.78 19.20% | 31.88 34.07% | 42.82 34.34% | 48.62 13.54% | 53.19 9.39% | 58.34 9.68% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.93 -3.82% | 4.47 9.54% | 3.81 30.56% | 3.05 44.51% | 7.78 12.36% | 4.98 11.46% | 4.62 21.07% | 3.51 15.27% |
| Revenue Q2Q % growth | 110.974B 1.28% | 114.678B 2.74% | 115.831B 2.36% | 115.409B 1.94% | 117.725B 6.08% | 119.22B 3.96% | 120.571B 4.09% | 120.724B 4.61% |
| EBITDA Q2Q % growth | 9.933B -2.43% | 7.111B -2.52% | 6.41B -15.20% | 5.658B 19.34% | 11.409B 14.86% | 7.528B 5.86% | 7.158B 11.67% | 5.912B 4.49% |
| EBIT Q2Q % growth | 8.792B -3.59% | 5.856B 13.71% | 5.379B 24.66% | 4.303B 1,032.37% | 10.152B 15.47% | 6.294B 7.48% | 5.871B 9.15% | 4.505B 4.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 2.11 -69.02% | 2.12 | -0.01 | -0.58% |
| Q3 2025 Q2Q % growth | 2.92 -59.16% | 2.82 | 0.10 | 3.48% |
| Q2 2025 Q2Q % growth | 4.08 -40.00% | 4.53 | -0.45 | -9.92% |
| Q1 2025 Q2Q % growth | 7.20 0.56% | 7.36 | -0.16 | -2.18% |
| Q4 2024 Q2Q % growth | 6.81 10.55% | 6.79 | 0.02 | 0.29% |
| Q3 2024 Q2Q % growth | 7.15 8.99% | 7.07 | 0.08 | 1.12% |
| Q2 2024 Q2Q % growth | 6.80 10.75% | 6.73 | 0.07 | 1.10% |
| Q1 2024 Q2Q % growth | 7.16 14.38% | 6.68 | 0.48 | 7.17% |
| Q4 2023 Q2Q % growth | 6.16 15.36% | 6.04 | 0.12 | 1.96% |
| Q3 2023 Q2Q % growth | 6.56 13.30% | 6.38 | 0.18 | 2.79% |
| Q2 2023 Q2Q % growth | 6.14 10.23% | 6.05 | 0.09 | 1.55% |
| Q1 2023 Q2Q % growth | 6.26 14.03% | 6.19 | 0.07 | 1.17% |
| Q4 2022 Q2Q % growth | 5.34 19.20% | 5.22 | 0.12 | 2.31% |
| Q3 2022 Q2Q % growth | 5.79 28.10% | 5.48 | 0.31 | 5.74% |
| Q2 2022 Q2Q % growth | 5.57 18.51% | 5.25 | 0.32 | 6.07% |
| Q1 2022 Q2Q % growth | 5.49 3.39% | 5.43 | 0.06 | 1.10% |
| Q4 2021 Q2Q % growth | 4.48 77.78% | 4.35 | 0.13 | 3.02% |
| Q3 2021 Q2Q % growth | 4.52 28.77% | 4.45 | 0.07 | 1.48% |
| Q2 2021 Q2Q % growth | 4.70 -33.99% | 4.48 | 0.22 | 4.95% |
| Q1 2021 Q2Q % growth | 5.31 42.74% | 4.43 | 0.88 | 19.95% |
| Q4 2020 Q2Q % growth | 2.52 | 2.44 | 0.08 | 3.42% |
| Q3 2020 Q2Q % growth | 3.51 | 3.12 | 0.39 | 12.37% |
| Q2 2020 Q2Q % growth | 7.12 | 5.33 | 1.79 | 33.60% |
| Q1 2020 Q2Q % growth | 3.72 | 3.66 | 0.06 | 1.58% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 113.215B 12.31% | 114.956B | -1.741B | -1.51% |
| Q3 2025 Q2Q % growth | 113.161B 12.24% | 114.195B | -1.034B | -0.91% |
| Q2 2025 Q2Q % growth | 111.616B 12.66% | 112.638B | -1.022B | -0.91% |
| Q1 2025 Q2Q % growth | 109.575B 9.49% | 112.718B | -3.143B | -2.79% |
| Q4 2024 Q2Q % growth | 100.807B 6.76% | 102.776B | -1.969B | -1.92% |
| Q3 2024 Q2Q % growth | 100.82B 9.16% | 100.272B | 548M | 0.55% |
| Q2 2024 Q2Q % growth | 99.075B 6.64% | 99.824B | -749M | -0.75% |
| Q1 2024 Q2Q % growth | 100.075B 8.86% | 100.256B | -181M | -0.18% |
| Q4 2023 Q2Q % growth | 94.427B 14.06% | 93.085B | 1.342B | 1.44% |
| Q3 2023 Q2Q % growth | 92.361B 14.18% | 92.325B | 36M | 0.04% |
| Q2 2023 Q2Q % growth | 92.903B 15.65% | 91.917B | 986M | 1.07% |
| Q1 2023 Q2Q % growth | 91.931B 14.70% | 90.677B | 1.254B | 1.38% |
| Q4 2022 Q2Q % growth | 82.787B 12.26% | 83.416B | -629M | -0.75% |
| Q3 2022 Q2Q % growth | 80.894B 11.83% | 81.308B | -414M | -0.51% |
| Q2 2022 Q2Q % growth | 80.332B 12.63% | 80.48B | -148M | -0.18% |
| Q1 2022 Q2Q % growth | 80.149B 14.18% | 79.574B | 575M | 0.72% |
| Q4 2021 Q2Q % growth | 73.743B 12.64% | 73.476B | 267M | 0.36% |
| Q3 2021 Q2Q % growth | 72.337B 11.09% | 71.941B | 396M | 0.55% |
| Q2 2021 Q2Q % growth | 71.321B 14.78% | 70.17B | 1.151B | 1.64% |
| Q1 2021 Q2Q % growth | 70.196B 8.96% | 69.909B | 287M | 0.41% |
| Q4 2020 Q2Q % growth | 65.467B | 65.713B | -246M | -0.37% |
| Q3 2020 Q2Q % growth | 65.115B | 64.522B | 593M | 0.92% |
| Q2 2020 Q2Q % growth | 62.138B | 64.131B | -1.993B | -3.11% |
| Q1 2020 Q2Q % growth | 64.421B | 64.961B | -540M | -0.83% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.45% | 8.02% | 0.43% | 1.05% |
| Revenue | -3.11% | -3.08% | -2.85% | -3.15% |